The activation strength of the innate immune pathway can also impact the anti-tumor effect of downstream molecules, as previously discussed molecules like IL-12 and IFN-α have concentration-dependent characteristics, and changes in their concentration can induce opposing effects. The gene discussed is IFNA1; the disease is neoplasm.